No products in the cart.

Chapter 54- Disorders of the Female Reproductive System

Porth's Pathophysiology, Concepts of Altered Health States 9th Edition by Sheila Grossman-Carol Mattson Porth

$2.99

Chapter 54- Disorders of the Female Reproductive System

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

1. After a long and frustrating course of constant vaginal pain, a 38-year-old woman has diagnosed with generalized vulvodynia by her gynecologist. What treatment plan is her physician most likely to propose?
  A) Alternative herbal therapies coupled with antifungal medications
  B) Antidepressant and antiepileptic medications
  C) Lifestyle modifications aimed at accommodating and managing neuropathic pain
  D) Narcotic analgesia and nonsteroidal anti-inflammatory medications
  Ans: B
  Feedback:
  Treatment of vulvodynia necessitates a long-term, chronic pain approach; antidepressants and antiepileptic medications are often used. Alternative therapies, standard analgesic regimens, and simple lifestyle modifications are less likely to be effective.

 

 

2. A 57-year-old woman has been diagnosed with atrophic vaginitis and has expressed surprise to her care provider, citing a lifetime largely free of gynecological health problems. She has asked what may have contributed to her problem. How can the care provider best respond?
  A) “The lower levels of estrogen since you’ve begun menopause make your vagina prone to infection.”
  B) “Vaginitis is not usually the direct result of any single problem, but rather an inevitability of the vaginal dryness that accompanies menopause.”
  C) “This type of vaginitis is most commonly a symptom of a latent sexually transmitted infection that you may have contracted in the distant past.”
  D) “The exact cause of this problem isn’t known, but it can usually be resolved with a diet high in probiotic bacteria.”
  Ans: A
  Feedback:
  The lack of vaginal epithelial regeneration after menopause predisposes older woman to vaginitis. It is not necessarily a result of vaginal dryness and is not likely sexually transmitted. The etiology is not unknown, and diet alone is unlikely to resolve the problem.

 

 

3. Which of the following women is most likely to have a sexually transmitted infection as a contributing factor to her health problem?
  A) A 29-year-old woman with a diagnosis of localized vulvodynia
  B) A 40-year-old who is being treated for vaginal cancer
  C) A 32-year-old who is undergoing diagnostics to rule out endometriosis
  D) A 41-year-old with a diagnosis of mucopurulent cervicitis
  Ans: D
  Feedback:
  While C. albicans, T. vaginalis, Neisseria gonorrhoeae, Gardnerella vaginalis, Chlamydia trachomatis, Ureaplasma urealyticum, and herpes simplex virus can all contribute to cervicitis. C. trachomatis is the organism most commonly associated with mucopurulent cervicitis. Vulvodynia, vaginal cancer, and endometriosis are less likely to have a sexually transmitted etiology.

 

 

4. While educating a mother about the benefits of giving her child the human papilloma virus (HPV) vaccine, gardisil, which of the following statements will the nurse need to clarify for the parent? Select all that apply. The vaccine is
  A) best administered before the child becomes sexually active.
  B) 100% effective against development of cervical cancer for her life span.
  C) effective against the two most common strains of genital warts.
  D) only recommended for females between the ages of 9 and 26.
  E) recommended prior to exposure to HPV, and if the child has genital warts, they are already exposed.
  Ans: B, D
  Feedback:
  The HPV vaccine has decreased the risk of cervical cancer by 97%. Gardisil is one type of HPV vaccine to prevent infection with the HPV subtypes 16, 18, 9, and 11. This vaccine has been approved for girls and boys between 9 and 26 years of age (prior to becoming sexually active) to prevent HPV 6 and 11 genital warts. The vaccine targets the two strains of HPV (16 and 18) responsible for 70% of the cervical cancer. There is no treatment that is 100% effective against cervical cancer.

Additional information

Add Review

Your email address will not be published. Required fields are marked *